SREBF1 and fatty liver disease: The current study confirmed that PD153035 significantly reduced PI3K/Akt signaling and SREBP-1 and 2 expression, preventing HFD-induced hepatic steatosis by reducing DNL and cholesterol synthesis and enhancing fatty acid oxidation.